The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Replacement of ixazomib for relapsed/refractory multiple myeloma patients refractory to a bortezomib or carfilzomib-containing combination therapy.
 
James R. Berenson
Employment - Oncotherapeutics; OncoTracker
Leadership - Oncotherapeutics; OncoTracker
Stock and Other Ownership Interests - Oncotherapeutics; OncoTracker
Honoraria - Various Pharma Companies
Consulting or Advisory Role - Various Pharma Companies
Speakers' Bureau - Various Pharma Companies
Research Funding - Institute for myeloma and Bone Cancer
Patents, Royalties, Other Intellectual Property - Through IMBCR and personally
Expert Testimony - Various Law Firms
Travel, Accommodations, Expenses - Various Pharma Companies
 
Alexa Cohen
Employment - Oncotherapeutics
 
Tanya M. Spektor
Employment - Oncotherapeutics
 
Jacob D. Bitran
No Relationships to Disclose
 
Gigi Qiqi Chen
No Relationships to Disclose
 
Mehdi M. Moezi
No Relationships to Disclose
 
Alberto Bessudo
No Relationships to Disclose
 
Joseph Z. Ye
No Relationships to Disclose
 
Steven Jeffrey Hager
No Relationships to Disclose
 
Robert A. Moss
No Relationships to Disclose
 
Alan D. Cartmell
No Relationships to Disclose
 
Teresa A. Coleman
No Relationships to Disclose
 
John Stewart Hrom
No Relationships to Disclose
 
Shahrooz Eshaghian
Consulting or Advisory Role - Astellas Pharma
 
Tina Maluso
No Relationships to Disclose
 
Regina A. Swift
Employment - James Berenson, M.D.
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Takeda
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Takeda
 
Stephen Lim
No Relationships to Disclose